2017
The role of technology in clinical trials using stereotactic body radiotherapy
Publication
Publication
British Journal of Radiology , Volume 90 - Issue 1071
Stereotactic body radiotherapy is a highly technology-driven treatment modality. The wider availability of in-room imaging and advanced radiotherapy delivery techniques has led to more institutions offering stereotactic ablative therapy (SABR). While some technological challenges remain, the crucial point for the next generation of SABR clinical trials is that today's technology is used correctly and close to its optimal potential for accuracy. The credentialing procedure of SABR needs to be extensive, but this investment will benefit the trial itself, the patients and the professionals involved.
| Additional Metadata | |
|---|---|
| doi.org/10.1259/bjr.20160930, hdl.handle.net/1765/98353 | |
| British Journal of Radiology | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Aznar, M. C., Romero, A., & Heijmen, B. (2017). The role of technology in clinical trials using stereotactic body radiotherapy. British Journal of Radiology (Vol. 90). doi:10.1259/bjr.20160930 |
|
